Haemonetics Corp expected to post earnings of 60  cents a share - Earnings Preview

Haemonetics

06/05/2022 11:02

* Haemonetics Corp  HAE.N   HAE  is expected to show a rise
in
quarterly revenue when it reports  results on May 10. 
    * The Boston Massachusetts-based  company is expected to
report  a
14.6% increase in revenue to $257.823 million from $225.03
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Haemonetics Corp is
for
earnings of 60 cents per share. For the same quarter last year,
the company reported earnings of 46 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $71​, above​ its last closing price of $51.08. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.73        0.73       0.84      Beat    14.4
 Sep. 30 2021  0.61        0.61       0.60      Missed  -1
 Jun. 30 2021  0.45        0.45       0.50      Beat    11.1​
 Mar. 31 2021  0.67        0.67       0.46      Missed  -31.5
 ​​Dec.        0.66        0.65       0.81      Beat    23.8
 31 2020                                                
 Sep. 30 2020  0.50        0.51       0.62      Beat    22.6​
 Jun. 30 2020  0.43        0.41       0.46      Beat    11.2
 Mar. 31 2020  0.73        0.73       0.69      Missed  -5.4
 This summary was machine generated May 6 at 10:02 GMT.  All
figures in US dollars  unless otherwise stated